Deutetrabenazine metabolite M4 is believed to be related to its effect as a reversible depletion of monoamines from nerve terminals. The major circulating metabolites of Deutetrabenazine, are reversible inhibitors of VMAT2, resulting in decreased uptake of monoamines into synaptic vesicles and depletion of monoamine stores.

1688661-95-1

C19H21D6NO4

339.46

SD-1018;Deuterated monohydroxy tetrabenazine;D6-tetrabenazine metabolite M4;Deutetrabenazine metabolite M4

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years